AngioDynamics, Inc. UG2.F Stock
AngioDynamics, Inc. Price Chart
AngioDynamics, Inc. UG2.F Financial and Trading Overview
AngioDynamics, Inc. stock price | 5.9 EUR |
Previous Close | 7.7 EUR |
Open | 7.65 EUR |
Bid | 7.9 EUR x 25800 |
Ask | 8.2 EUR x 24800 |
Day's Range | 7.65 - 8.05 EUR |
52 Week Range | 7.3 - 23.2 EUR |
Volume | 310 EUR |
Avg. Volume | 14 EUR |
Market Cap | 324.93M EUR |
Beta (5Y Monthly) | 0.609975 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.48 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 30 EUR |
UG2.F Valuation Measures
Enterprise Value | 317.89M EUR |
Trailing P/E | N/A |
Forward P/E | 53.666664 |
PEG Ratio (5 yr expected) | 190 |
Price/Sales (ttm) | 0.9592098 |
Price/Book (mrq) | 0.8429319 |
Enterprise Value/Revenue | 0.938 |
Enterprise Value/EBITDA | 26.069 |
Trading Information
AngioDynamics, Inc. Stock Price History
Beta (5Y Monthly) | 0.609975 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 23.2 EUR |
52 Week Low | 7.3 EUR |
50-Day Moving Average | 8.55 EUR |
200-Day Moving Average | 10.42 EUR |
UG2.F Share Statistics
Avg. Volume (3 month) | 14 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 39.67M |
Float | 38.48M |
Short Ratio | N/A |
% Held by Insiders | 5.76% |
% Held by Institutions | 88.87% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | May 31, 2023 |
Most Recent Quarter (mrq) | May 31, 2023 |
Next Fiscal Year End | May 31, 2024 |
Profitability
Profit Margin | -15.48% |
Operating Margin (ttm) | -5.51% |
Gross Margin | 51.43% |
EBITDA Margin | 3.59% |
Management Effectiveness
Return on Assets (ttm) | -2.15% |
Return on Equity (ttm) | -13.064% |
Income Statement
Revenue (ttm) | 338.75M EUR |
Revenue Per Share (ttm) | 8.58 EUR |
Quarterly Revenue Growth (yoy) | 4.70% |
Gross Profit (ttm) | 174.25M EUR |
EBITDA | 12.19M EUR |
Net Income Avi to Common (ttm) | -52442000 EUR |
Diluted EPS (ttm) | -1.22 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 44.62M EUR |
Total Cash Per Share (mrq) | 1.13 EUR |
Total Debt (mrq) | 55.06M EUR |
Total Debt/Equity (mrq) | 14.55 EUR |
Current Ratio (mrq) | 1.951 |
Book Value Per Share (mrq) | 9.55 |
Cash Flow Statement
Operating Cash Flow (ttm) | 78K EUR |
Levered Free Cash Flow (ttm) | 30.05M EUR |
Profile of AngioDynamics, Inc.
Country | Germany |
State | NY |
City | Latham |
Address | 14 Plaza Drive |
ZIP | 12110 |
Phone | 518 795 1400 |
Website | https://www.angiodynamics.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 815 |
AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Q&A For AngioDynamics, Inc. Stock
What is a current UG2.F stock price?
AngioDynamics, Inc. UG2.F stock price today per share is 5.9 EUR.
How to purchase AngioDynamics, Inc. stock?
You can buy UG2.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AngioDynamics, Inc.?
The stock symbol or ticker of AngioDynamics, Inc. is UG2.F.
Which industry does the AngioDynamics, Inc. company belong to?
The AngioDynamics, Inc. industry is Medical Instruments & Supplies.
How many shares does AngioDynamics, Inc. have in circulation?
The max supply of AngioDynamics, Inc. shares is 40.32M.
What is AngioDynamics, Inc. Price to Earnings Ratio (PE Ratio)?
AngioDynamics, Inc. PE Ratio is now.
What was AngioDynamics, Inc. earnings per share over the trailing 12 months (TTM)?
AngioDynamics, Inc. EPS is -4.48 EUR over the trailing 12 months.
Which sector does the AngioDynamics, Inc. company belong to?
The AngioDynamics, Inc. sector is Healthcare.